Skip to main content
Clinical Trials/NCT04424368
NCT04424368
Unknown
Not Applicable

Creation and Evaluation of the Effectiveness of the Remote Monitoring System for Patients, Who Had Myocardial Infarction

Ryazan State Medical University1 site in 1 country250 target enrollmentOctober 3, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Ryazan State Medical University
Enrollment
250
Locations
1
Primary Endpoint
hospitalization
Last Updated
4 years ago

Overview

Brief Summary

one-centered, open, prospective, non-randomized, controlled clinical study will be aimed at creating remote monitoring system for patients' condition and the development of methodological approaches and its usage for conducting patients, who had myocardial infraction and who has a very high risk of developing an unfavorable outcome.

Detailed Description

The research will involve patients, who had myocardial infraction and who has the high level of potential adherence to treatment, which will be determined by the usage of Russian generic questionnaire for evaluation of compliance to drug therapy. At the end of a 12 month observation with the registration of unfavorable cardiovascular occasions (death from cardiovascular reasons, nonfatal myocardial infraction, cerebral stroke, necessity for repeated revascularization of the coronary arteries) based on the analysis of non-genetic and genetic factors (polymorphism of genes Thr174Met and Met235Thr in gene angiotensinogen, Arg389Gly and Ser49Gly in gene adrenoceptor beta 1, Ser447Ter in gene lipoprotein lipase and Leu28Pro in gene apolipoprotein E, Trp212Ter and G681A in gene cytochrome P450 family 2 subfamily C member 19) factors of unfavorable prognosis will be identified and considering which group of patients requires the use of remote monitoring system will be formed. From one group of patients we will form two comparable groups, one group will use this remote monitoring system and another will not. The effectiveness of the remote monitoring system will be evaluated after 6-month's observation based on the registration of the unfavorable cardiovascular occasions (death from cardiovascular reasons, nonfatal myocardial infraction, cerebral stroke, necessity for repeated revascularization of the coronary arteries, frequency of hospitalizations).

Registry
clinicaltrials.gov
Start Date
October 3, 2018
End Date
December 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A significant diagnosis of myocardial infraction, confirmed by the level of biomarkers of myocardial necrosis in blood examination (troponin, creatine kinase-MV), electrocardiographic criteria, typical clinical presentation.
  • The high level of adherence to treatment
  • Signed informed agreement

Exclusion Criteria

  • Active cancer or remission period less than 5 years;
  • Absolute contradictions to the prescription of beta-adrenergic blocking agents, angiotensin converting enzyme inhibitors, statins, antiaggregants.
  • Mental illnesses.
  • Alcohol and drug abuse
  • Patient's noncompliance, according to the researchers

Outcomes

Primary Outcomes

hospitalization

Time Frame: 12 months

frequency of hospitalization about the progression of coronary heart disease

revascularization

Time Frame: 12 months

frequency of repeated revascularization of coronary arteries

cardiovascular mortality

Time Frame: 12 months

the number of deaths from cardiovascular causes

acute myocardial infarction

Time Frame: 12 months

incidence of acute myocardial infarction

cerebral stroke

Time Frame: 12 months

incidence of cerebral stroke

Study Sites (1)

Loading locations...

Similar Trials